APA (7th ed.) Citation

Xiao, Y., Ma, D., Yang, Y., Yang, F., Ding, J., Gong, Y., . . . Jiang, Y. (2022). Comprehensive metabolomics expands precision medicine for triple-negative breast cancer. Cell research, 32(5), 477-490. https://doi.org/10.1038/s41422-022-00614-0

Chicago Style (17th ed.) Citation

Xiao, Yi, et al. "Comprehensive Metabolomics Expands Precision Medicine for Triple-negative Breast Cancer." Cell Research 32, no. 5 (2022): 477-490. https://doi.org/10.1038/s41422-022-00614-0.

MLA (9th ed.) Citation

Xiao, Yi, et al. "Comprehensive Metabolomics Expands Precision Medicine for Triple-negative Breast Cancer." Cell Research, vol. 32, no. 5, 2022, pp. 477-490, https://doi.org/10.1038/s41422-022-00614-0.